Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
From - Diagnostic Testing & Emerging Technologies Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article